Tech Company Financing Transactions

Elephas Biosciences Funding Round

Elephas Biosciences, based in Madison, received $41.5 million from Arch Venture Partners, Moore Strategic Ventures and Northpond Ventures.

Transaction Overview

Announced On
9/7/2022
Transaction Type
Venture Equity
Amount
$41,500,000
Round
Series B
Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
918 Deming Way 201
Madison, WI 53717
USA
Phone
Undisclosed
Email Address
Not Recorded
Overview
Elephas is solving this problem by developing an imaging platform technology to assess how live tumor fragments respond to cancer therapies. We are removing the trial-and-error approach to cancer care by harnessing the latest advances in cancer biology, multimodal microscopy, and artificial intelligence to accelerate drug development and empower clinical decision making.
Profile
Elephas Biosciences LinkedIn Company Profile
Social Media
Elephas Biosciences Company Twitter Account
Company News
Elephas Biosciences News
Facebook
Elephas Biosciences on Facebook
YouTube
Elephas Biosciences on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Maneesh Arora
  Maneesh Arora LinkedIn Profile  Maneesh Arora Twitter Account  Maneesh Arora News  Maneesh Arora on Facebook
Chief Financial Officer
Terry Brady
  Terry Brady LinkedIn Profile  Terry Brady Twitter Account  Terry Brady News  Terry Brady on Facebook
Chief Scientific Officer
Jonathan Oliner
  Jonathan Oliner LinkedIn Profile  Jonathan Oliner Twitter Account  Jonathan Oliner News  Jonathan Oliner on Facebook
Vice President
Hinco Gierman
  Hinco Gierman LinkedIn Profile  Hinco Gierman Twitter Account  Hinco Gierman News  Hinco Gierman on Facebook
VP - Engineering
Pascual Starink
  Pascual Starink LinkedIn Profile  Pascual Starink Twitter Account  Pascual Starink News  Pascual Starink on Facebook
VP - Engineering
Mike Szulczewski
  Mike Szulczewski LinkedIn Profile  Mike Szulczewski Twitter Account  Mike Szulczewski News  Mike Szulczewski on Facebook
VP - Regulatory Affairs
Ann Leonard
  Ann Leonard LinkedIn Profile  Ann Leonard Twitter Account  Ann Leonard News  Ann Leonard on Facebook


 

 

Browse more venture capital transactions:

Prev: 9/7/2022: Taranis venture capital transaction
Next: 9/7/2022: Chargezoom venture capital transaction

 

Share this article

 


Where The Data Comes From

Our team works diligently to report on every notable VC transaction. VC investment data records reported here are sourced from publicly available VC deal announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary